BMRA's logo.
Ticker Symbol: BMRA

Biomerica Inc.

$4.72 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0000073290

Company Profile

biomerica, inc. (www.biomerica.com) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. the company’s products are designed to enhance health and well-being, while reducing total healthcare costs. biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. the biomerica infoods® ibs product identifies patient specific foods that when removed may alleviate an individual's ibs symptoms. this patent pending diagnostic guided therapy is designed to allow for a patient specific guided dietary regimen to improve irritable bowel syndrome (ibs) outcomes. the point-of-care product is being developed to allow physicians to perform the test in-office using a finger stick blood sample while a clinical lab version of the product will be the first for wh

Sector: Manufacturing
Industry: Dental Equipment and Supplies Manufacturing
Standard Industrial Classification Code (SIC code): 3843
Address: N/A
Website: biomerica.com
CEO: N/A
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Dental Equipment and Supplies Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.80
Change: $0.01 ( 2.20%)
Days Range: $0.79 - $0.80
Beta: 0.44
52wk. High: $4.17
52wk. Low: $0.70
Ytd. Change -73.92%
50 Day Moving Average: $0.93
200 Day Moving Average: $1.29
Shares Outstanding: 16821646

Valuation

Market Cap: 1.3B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A